Trial Profile
The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Oct 2014
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ACCELERATE
- Sponsors The Medicines Company
- 07 May 2012 Planned number of patients changed from 40 to 60 as repored by European Clinical Trials Database.
- 07 May 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000230-53).
- 12 May 2010 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov record.